SpineGuard Announces Its 2024 Financial Calendar
20 Dicembre 2023 - 6:00PM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an
innovative company that deploys its DSG (Dynamic Surgical Guidance)
sensing technology to secure and streamline the placement of bone
implants, announced today its schedule for the publication of
financial information for 2024.
2024 financial calendar
Event
Date*
2023 Full-Year Sales
January 10, 2024
2023 Full-Year Results
April 17, 2024
2024 First-Quarter Sales
April 17, 2024
Annual Shareholders Meeting
June 5, 2024 (1st summoning)
June 26, 2024 (2nd summoning if
required)
2024 First-Half Sales
July 10, 2024
2024 First-Half Results
September 11, 2024
2024 Third-Quarter Sales
October 9, 2024
Note (*): Press releases are published after stock market
closes. This information is subject to modification.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices embedding its technology. Over 95,000
surgical procedures have been secured worldwide thanks to DSG® and
29 studies published in peer-reviewed scientific journals have
demonstrated the multiple benefits DSG® offers to patients,
surgeons, surgical staff and hospitals. Building on these strong
fundamentals and several strategic partnerships, SpineGuard is
expanding the scope of its DSG® technology to the treatment of
scoliosis via anterior approach, sacroiliac joint fusion, dental
implantology and innovations such as the « smart » pedicle screw
and power drill or surgical robotics. DSG® was co-invented by
Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain
Vanquaethem, Biomedical Engineer. SpineGuard has engaged in
multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231220007523/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Anne-Charlotte Millard Chief Financial Officer
Tel.: +33 1 45 18 45 19 ac.millard@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Aurélie Manavarere Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Grafico Azioni Spineguard (EU:ALSGD)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Spineguard (EU:ALSGD)
Storico
Da Apr 2023 a Apr 2024
